The optimization of continuous ambulatory peritoneal dialysis  by Oreopoulos, Dimitrios G.
Kidney International, Vol. 55 (1999), pp. 1131–1149
NEPHROLOGY FORUM
The optimization of continuous ambulatory peritoneal dialysis
Principal discussant: Dimitrios G. Oreopoulos
The Toronto Hospital and University of Toronto, Toronto, Canada
medication, but he required medication thereafter. He had no
episodes of peritonitis and gained 5 kg. However, his urine
output gradually declined despite large doses of furosemide.
At the beginning of the third year, despite an increasing dose
and number of antihypertensive medications, he complained
of progressive fatigue, anorexia, and ankle swelling. He was
hypertensive (blood pressure, 180/100 mm Hg), and his urine
output was negligible. His serum albumin had decreased to 3.0
g/dl, the blood urea had decreased to 12 mm/liter, and the
serum creatinine was 1100 mm/liter (12.5 mg/dl). On repeat
assessment, his clearances were KT/V, 1.55 (1.45 peritoneal
and 0.1 renal), and WCC, 48 liters (42 liters peritoneal and 6
liters renal). His NPNA had decreased to 0.65 g/kg/day. His
weight had increased by 3 kg and he was edematous.
His CAPD prescription was increased to 2.5 liters 4 times
daily, after which his KT/V increased to 1.75 (1.65 peritonealCASE PRESENTATION
and 0.1 renal) and his weekly creatinine clearance to 58 litersA 55-year-old Greek Canadian, a restaurant owner, devel- (52 liters peritoneal and 6 liters renal). After 3 months, hisoped end-stage renal disease secondary to proliferative glomer- NPNA remained low at 0.60 g/kg/day. His uremic symptomsulonephritis of 3 years’ duration. Because he was fatigued, had and hypertension became worse, and he could not achievea poor appetite with occasional morning nausea, and could not his target weight despite three hypertonic exchanges per day.sleep well, he began continuous ambulatory peritoneal dialysis Average ultrafiltration with 2.5% glucose at four hours was 25(CAPD) 5 years ago through a surgically implanted Toronto
ml, and with 4.25% glucose was 180 ml. Dialysate protein lossesWestern peritoneal catheter. At that time his weight was 71 kg
were 12 g/day and his serum albumin fell to 2.8 g/dl. Because hisand body surface area 1.76 m2. He had substantial residual renal
condition was getting worse, he was transferred to automatedfunction, with a 24-hour creatinine clearance of 9.0 ml/min, a
peritoneal dialysis (APD) with 4 3 2.8 liter exchange over nineurea clearance of 4.3 ml/min, and a urine volume of 1100 ml/
hours each night and a three-hour 2.5 liter exchange eachday. Initial biochemical investigations showed a serum albumin
evening.of 3.5 g/dl (Bromcresol green method); hemoglobin, 10.1 g/dl;
On this regimen, his KT/V was 2.1 and creatinine clearanceand hematocrit, 33%. He was started on a “standard” CAPD
60 liters/week. Furthermore, his net ultrafiltration increased,regimen of 2-liter exchanges four times daily. At the end of
he attained his target weight and, after six months, his NPNAthe second week, clearance measurements with the Adequestt
had increased to 0.8 g/kg/day, but his serum albumin remainedprogram were as follows: D/P creatinine, 0.85; KT/V (urea),
low at 3.1 g/dl. Clinically he felt better. He was able to sleep2.57 (1.07 renal and 1.5 peritoneal); weekly creatinine clearance
well and he resumed working part-time work in his restaurant.(WCC) corrected for 1.73 m2 BSA, 113 liters (65 liters renal
Three months later he received a successful transplant with aand 48 liters peritoneal); and normalized equivalent of protein
cadaveric kidney.nitrogen appearance (NPNA), 0.8 g/kg/day. The blood urea
was 20 mm/liter; serum creatinine, 416 mm/liter (4.7 mg/dl); and
blood pressure, 150/80 mm Hg.
DISCUSSIONFor the next two years he did well on CAPD. He felt well
and continued working in his restaurant. His appetite was good, Dr. Dimitrios G. Oreopoulos (Director, Peritoneal
he slept well, and he had an active sexual life. For the first Dialysis Program, The Toronto Hospital—Western Divi-
year, his blood pressure was normal without antihypertensive
sion, and Professor of Medicine, University of Toronto,
Toronto, Ontario, Canada): A Nephrology Forum given
in 1983 by Dr. Stephen Vas [1] was devoted to the diag-Presentation of this Forum is made possible by grants from Merck &
Company, Incorporated; Astra Pharmaceuticals; Hoechst Marion nosis and treatment of peritonitis—at that time, the main
Roussel, Incorporated; Dialysis Clinic, Incorporated; and R & D Labo- complication of CAPD. Since then, the introduction ofratories, Incorporated.
several disconnect systems has decreased the rate of peri-
Key words: chronic renal failure, peritoneal dialysis, nutrition, adequacy. tonitis substantially. Although it is still a serious compli-
cation, peritonitis is no longer the main reason resulting 1999 by the International Society of Nephrology
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in discontinuation of CAPD and transfer to hemodialysis In the 1960s and 1970s, clinicians based their defini-
tions of adequacy of dialysis on their clinical acumen(HD). Instead, the main cause for failure of CAPD in
Canada currently is inadequate dialysis; 12% of CAPD and a review of classic biochemical parameters such as
blood urea, creatinine level, and hematocrit. These pa-patients fail for this reason versus 8.6% because of peri-
tonitis [2]. Underdialysis is now common among CAPD rameters remain valid, albeit insufficient, criteria for de-
termining the adequacy of dialysis. Symptoms and signspatients because an increasing number have been treated
with this technique for more than three years, an interval of underdialysis such as nausea, vomiting, fatigue, weak-
ness, insomnia, and restless legs also should be rigorouslyover which residual renal function usually declines to zero.
Today’s patient, a 55-year-old man with high perito- sought in assessing the adequacy of dialysis. These latter
criteria can be due to other causes, however, and it isneal permeability (defined by D/P creatinine . 0.80) was
started relatively early on dialysis. That is, his endoge- difficult to quantitate them. For these reasons, these
symptoms and signs are not sufficient for defining ade-nous creatinine clearance (CCr) was 9.0 ml/min. The low
serum albumin (3.5 g/dl) at the start of dialysis might quacy and predicting outcome. Furthermore, one might
not recognize underdialysis early if one bases the diagno-have been due to a combination of factors such as pro-
teinuria, about which we have no information, and an sis only on clinical and biochemical parameters, and it
might not be possible to “catch up” if the dose of dialysisinadequate protein intake. His clinical symptoms im-
proved and his elevated blood pressure was controlled is not increased soon after underdialysis begins. We
therefore need now objective, quantifiable parametersby CAPD. In addition, his appetite improved and he
gained weight. By the end of the second year, however, by which we can assess adequacy of dialysis and detect
underdialysis before clinical symptoms and signs appear.he again became uremic and hypertension returned; a
further decrease in his serum albumin and a decrease in In this presentation I will discuss only three major
dialysis-related factors that can predict outcome, and Iblood urea indicated low protein intake and confirmed
the low NPNA of 0.65 g/kg/day. These changes primarily will discuss the relationship among them: small-solute
clearances, nutrition, and fluid/volume control. Thesereflect the decline in his residual renal function with the
resulting inadequate clearance of urea and creatinine. three factors probably are interrelated, and achieving
adequate dialysis requires that we address all three to-An increase in the dialysis solution volume to 10 liters/
day did not improve his symptoms or correct his signifi- gether. Optimization of all three clearly will improve
outcomes for all our CAPD patients. I will not examinecant ultrafiltration failure secondary to his high transport
state (that is, fast glucose absorption causing dissipation the effect of cardiovascular disease, lipid abnormalities
and their control on dialysis outcome, or issues concern-of the osmotic gradient responsible for ultrafiltration).
His clinical condition improved, however, after his ing quality of life, not because they are not important,
but because I believe their impact on patient survivaldialysis technique was converted to APD, an enhanced
type of dialysis with short night exchanges of large vol- deserves a separate discussion.
umes, and one relatively long (3-hour) exchange during
Small-solute clearancesthe daytime. His urea and creatinine clearances im-
proved, and his fluid status was better controlled. After The National Cooperative Dialysis Study (NCDS), the
first attempt at providing objective parameters of ade-six months, his NPNA increased but his serum albumin
level remained low. This man’s history demonstrates all quacy [5], showed that parameters derived from urea
kinetic modeling (UKM) best describe the adequacy ofthe points about adequacy of peritoneal dialysis that I
will discuss during this Forum, specifically, the clearance hemodialysis. According to that study, indicators of a
low morbidity are an NPNA . 1 g/kg/day, and a time-of small molecules (KT/V urea, WCC), the importance
of residual renal function, the central role of malnutri- averaged concentration of BUN <50 mg/dl. Based on
the results of the NCDS study, Gotch and Sargent devel-tion, the phenomenon of high peritoneal permeability
and, finally, the importance of fluid/volume overload and oped the concept of KT/V that integrated efficiency of
solute clearance (K), treatment time (T), and patientits control.
When physicians devise regimens for patients with size (V) [6]. This dimensionless measure of fractional
clearance of body water for urea has been accepted andchronic renal failure, the treatment is optimal if it elimi-
nates all signs and symptoms of the disease and ensures validated as an index of adequacy for hemodialysis. After
establishing that KT/V was a reliable predictor of out-the same life expectancy as they would have in the ab-
sence of the disease. With few exceptions, however [3], come in hemodialysis, it was reasonable to extrapolate
these same concepts to the prediction of outcome inthe life expectancy of dialysis patients is much shorter
than that of an aged-matched population, and the term patients on peritoneal dialysis. In hemodialysis, the rate
of solute removal changes during dialysis because the“adequate dialysis” is a compromise that implies an “ac-
ceptable outcome,” which one hopes will be close to concentration of blood urea decreases during dialysis.
In CAPD, because the blood urea concentration is rela-optimal [4].
Nephrology Forum: Optimization of CAPD 1133
tively constant, clearance and solute removal stay about
the same and are related in a linear fashion. In most
CAPD patients, the urea in dialysate and plasma achieve
virtual equilibrium. Thus, given the stable blood urea
concentration, the drain volume is equivalent to urea
removal (KT) [4]. This constant relationship between
blood levels and removal rate allows continuous treat-
ments like CAPD to remove the same volume of solute
per week as does thrice-weekly hemodialysis sessions,
even though the clearance rates are substantially lower:
5 to 10 ml/min for CAPD versus 200 to 300 ml/min for
HD [7, 8]. Teehan et al, who first applied the UKM
Fig. 1. Equivalence of CAPD and HD KT/Vs based on the peak con-principle to CAPD, showed that measurements of BUN,
centration hypothesis. (From Ref. 15.)
NPNA, and KT/V provide a reasonable basis for uniform
prescription of peritoneal dialysis and allow comparison
of treatment between patients and centers as well as
optimization of dialysis and nutrition during therapy [9]. work group for the malnourished patient, in whom no
other cause of malnutrition is discovered, is to increaseMeasuring KT/V in PD patients. After repeated mea-
surements of KTrp/V, which includes both the contribu- the dose of dialysis by multiplying the target KT/V by
the ratio V desired/V actual [13].tion of the renal (KTr/V) and the peritoneal clearance
(KTp/V), the coefficient of variation is 8% [10]. The Comparing KT/V targets in PD and HD: A paradox.
Although it is logical to attempt to extrapolate UKMgreatest variability is seen with KTr/V (35%); only mod-
erate variability is seen for KTp/V (7%) [10]. The renal data from patients treated with HD to those treated with
PD, it is paradoxical that the typical KT/V delivered tocomponent varies even more widely when the amount
of urine excreted in 24 hours is very low (1–2 voidings/ CAPD patients is between 1.2 and 2.4 per week [14]. By
HD standards, this figure is well below the accepted levelday), in which case calculations of clearance should be
based on a 48-hour urine collection. of 3.0 to 3.6/week; however, numerous comparisons of
the two modalities have shown no difference in morbid-The peritoneal component (KTp/V) of KTrp/V varies
chiefly because of variations in the calculation of V, ity and mortality. Keshaviah and colleagues have tried to
resolve this paradox by invoking the peak concentrationthat is, the volume of distribution of urea. For practical
purposes, this is considered equal to the total-body wa- hypothesis [15], which asserts that the success of CAPD
is related to its continuous, steady-state nature. If uremicter, although studies using isotopes of urea found that
urea distribution space can be smaller than total-body toxicity is associated with the peak concentration of BUN
rather than its time-average value, then in hemodialysiswater space by approximately 12% to 14% [11]. Total
body water (V) can be estimated as a fixed fraction of patients, for approximately one-half of the week the
BUN will exceed the time-average urea concentrationbody weight (60% of BW for men and 55% of BW for
women) or an average of 58% for any individual, or by (TAC). Therefore, for hemodialysis the KT/V would
have to be higher than that of CAPD to keep the peakanthropometric formulas such as the Watson formula,
which most investigators now consider the method of BUN at the same level and achieve equivalent control
of uremia [16]. On the basis of this hypothesis, Keshaviahchoice [12].
Because no agreement has been reached concerning calculated that, for a hemodialysis KT/V of 1.3 per treat-
ment, the corresponding weekly CAPD KT/V is 2.0.the weight to be used in estimating V, different results
of KT/V have been reported. In general, estimates of V (Fig. 1) [15]. Other possible reasons why CAPD patients
appear to need less urea clearance compared to thosebased on actual weight should be most accurate when
actual and desired (ideal) weight do not differ greatly on hemodialysis include the lack of changes in hydration
and blood pH, the high clearance of large or middle[12]. In obese patients (wt . 20% of ideal BW), V should
be calculated using ideal BW [12]. Otherwise, the V will molecules, a less catabolic environment, and better pres-
ervation of residual renal function (RRF).be overestimated and KT/V underestimated. In wasted
patients, KT/V will be misleadingly high if one uses ac- The rate of decline in residual renal function appears
slower in PD than in HD [17, 18]. Possible reasons fortual body weight for the calculation of V; instead, to
derive a KT/V indicative of a dialysis dose related to a this difference are: (1) stable high BUN levels in CAPD;
(2) absence of marked fluid shifts permitting hemody-healthier weight, one should use standard body weight,
which can be obtained after calculating V with the Wat- namic stability and avoidance of glomerular ischemia; (3)
reduced dietary protein intake combined with increasedson formula and dividing it by 0.58 [9]. The recommenda-
tion of the Dialysis Outcome Quality Initiative (DOQI) protein losses in dialysate; (4) absence of cytokine-medi-
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Table 1. Summary of studies investigating KT/V targets for CAPDa USA study provides the best support for a correlation
between small-solute clearance and patient outcomeTargets based on Recommended
theoretical constructs KT/V target Comment [23]. This study followed for a minimum of two years
Popovich et al 2.0 680 patients who started CAPD in 14 centers in Canada
Teehan 2.25 and the US. Analysis of survival showed that, during these
Keshaviah 2.0
two years, both dialysis dose and non-dialysis-related
Prospective cohort studies/
factors were related to the likelihood of death. Whenunivariate analysis
Teehan 1.83 Improved survival the Cox proportional hazards model was used with dial-
DeAlvaro 2.0 Better survival than ysis dose and nutritional status as time-dependent covari-
KT/V 1.7
ants, the relative risk of death increased with increasingLameire 1.85 Survival . 5 years
Brandes .2.5 Better survival than age, insulin-dependent diabetes mellitus (IDDM), car-
KT/V , 1.5 diovascular disease, decreasing serum albumin, poor nu-
Blake ,1.50 Increased
tritional status, and being dialyzed in the US. Highermortality
Arkouche .2.3 Better clinical outcome clearance, inclusive of residual renal function, was associ-
than KT/V , 1.6 ated with better patient survival, ability to continue treat-
Lameire .2.4 Fewer hospitalizations
ment with CAPD, and less frequent hospitalization. The
a From Ref. 19 expected two-year patient survival based on sustained
KT/V and creatinine clearance steadily increased over
the range of values studied; no plateau effect was seen
at the highest doses of KT/V (2.3) or creatinine clearanceated responses to extracorporeal exposure to dialysis
membrane; and (5) the continuous volume-expanded (95/liters/week/1.73 m2 BSA); hence no minimum target
could be set. The higher the weekly KT/V urea and creati-state that often is associated with CAPD [17, 18]. I will
return to the importance of residual renal function in nine clearance, the better the survival.
One should be cautious when interpreting the CAN-small solute clearance and nutrition in a few moments.
What level of KT/V (urea) gives an acceptable out- USA results; these data are inferences from a statistical
model and are not derived from a prospective controlledcome? Churchill recently reviewed all studies that at-
tempted to determine adequate targets of weekly KT/V study. Although the study showed a clear association
between dose and outcome, it does not ensure causality.urea [19]. He divided the studies into three groups: those
that base KT/V targets on theoretical constructs, pro- Furthermore, the CANUSA and other studies that sug-
gest that targets of dialysis adequacy correlate with pa-spective studies using univariate analysis, and prospec-
tive studies using multivariate analysis. Table 1 summa- tient outcome base their conclusions on adequacy values
that include both dialysis and residual renal clearancerizes the results of the theoretical constructs and those
based on cohort studies with univariate analysis. With a [20, 23]. However, in all of them the decline of the renal
component of KT/V (KTr/V) over time is responsiblefew exceptions, most studies seem to indicate that a
weekly KT/V $ 1.9 provides better survival and a better for most of the variation in total clearance because the
peritoneal clearance remains relatively stable [20, 23–25].clinical outcome.
Four prospective controlled studies have used multi- Recent analysis of the CANUSA results indicated that
changes in residual renal function, but not those in peri-variate analysis to assess the relationship between KT/
V and outcome and to define other independent vari- toneal clearance, were significantly correlated with out-
come [26]; in other words, the CANUSA and similarables that predict increased risk of death [20–23]. Teehan
et al, who studied 51 patients over a period of five years, studies show that, as residual renal function declined,
mortality increased. Today we have no study that indi-found that decreased serum albumin, older age, longer
time on CAPD, and decreased KT/V were associated cates whether one can improve outcome by increasing
peritoneal clearance to compensate for declining renalwith decreased survival [20]. Genestier and colleagues
found that older age, cardiovascular disease, diabetes, function. Recently, however, we retrospectively reviewed
115 anuric CAPD patients in our program and correlatedworse comorbidity score, and lower initial KT/V and
WCC were associated with a worse survival in their study peritoneal KT/V with outcome (Fig. 2; unpublished data).
Those who had a KTp/V of ,1.75 had a significantlyof 201 patients [21]. Maiorca and coworkers, who studied
68 prevalent patients over three years, determined that higher mortality rate than did patients whose KTp/V ex-
ceeded 1.75 (Fig. 2). In other words, there is a minimumolder age, peripheral vascular disease, dyslipidemia, ar-
rhythmia, initial serum albumin , 3.5 g/dl, and weekly peritoneal urea clearance (KTp/V of 1.75) below which
mortality is increased.KT/V , 1.7 were detrimental factors [22]. The presence
of residual renal function and a KT/V . 1.98 were associ- Not all studies have confirmed the correlation between
KT/V and patient outcome [24, 27]. This variability inated with significantly better survival.
Although not a randomized controlled trial, the CAN- the published results is due partially to differences in
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mended in the late 1970s a weekly creatinine clearance
of 100 liters for hemodialysis and 50 liters for peritoneal
dialysis [29]. Subsequently, Twardowski and colleagues
recommended 40 to 50 liters/1.73 m2 BSA based on their
clinical experience [30]. Arkouche and coworkers found
these levels inadequate and proposed higher levels, 60
liters/week/1.73 m2 BSA [31]. Maiorca et al concluded
that, for a KT/V of 1.96, above which survival was excel-
lent, the equivalent WCC was 58 liters [22]. According to
the CANUSA study, the higher the creatinine clearance
(sum of renal and peritoneal), the better the outcome,
and a clearance of 70 liter/1.73 m2 was associated with
a 78% survival at 2 years, the same as a KT/V of .2.1
[23]. The targets recommended by DOQI for continuous
treatments such as CAPD and CCPD (WCC of 60 liters/
1.73 m2) are slightly lower than the target of WCC . 70
liters, which one would deduce from the CANUSA
study. Selgas et al found that WCC was a much weakerFig. 2. Comparison of anuric CAPD patients with KTp/V values above
predictor of outcome than urea clearance [32]. Similarly,(j) or below (s) 1.75. (P , 0.05.)
Blake et al noted no relationship between total WCC
and mortality except for WCC values , 48 liters/1.73 m2
[33]. No consensus exists as to whether urea or creatinine
the size of the patient groups, the heterogeneity of the clearance is a better marker of adequacy. In fact, in
population, the length of study periods [21], differences about 20% of patients, one finds a distinct dissociation
in weight used to calculate V, and the inclusion in the between these two markers [34].
analysis of the risk factors I have noted, the hazards of Discrepancy between KT/V and weekly creatinine
which are not proportional. Furthermore, as I will discuss clearance can be due to (1) the different levels of residual
later, inclusion in the analysis of “high transporters,” renal function, (2) the difference in the rate of equilibra-
who though they have high small-solute (especially creat- tion for urea and creatinine between plasma and the
inine) clearances, still have a high mortality rate, makes
dialysis solution, and (3) the utilization of different nor-
the interpretation of the correlations more difficult.
malizing constant (that is, V for urea and body surface
Based on the results of these studies, the Dialysis Out-
area for creatinine). Thus in a group of CAPD patientscome Quality Initiative working group [13] and an ad hoc
with some residual renal function, renal KTr/V urea con-committee of experts [28] recommended rather arbitrary
tributed on average only 17% to the total KTrp/V,minimum clearance targets for CAPD patients, namely,
whereas the renal creatinine clearance contributed 35%KT/V . 2.0 and weekly creatinine clearance . 60 liters/
to the overall creatinine clearance [35]. This difference1.73 m2. Until our previously mentioned experience with
was due to the reabsorption of urea and the secretionanuric CAPD patients is further investigated with pro-
of creatinine in the renal tubules; therefore, early inspective controlled studies, it is reasonable to consider
CAPD, when patients have some residual renal function,as equivalent the renal and peritoneal clearances and to
it is easier to achieve creatinine clearance targets thancompensate for the declining residual renal function by
KT/V urea targets. On the contrary, when patients be-increasing the peritoneal dose to achieve the recom-
come anuric, it is easier to achieve KT/V urea targetsmended target [13]. Are the same target levels appro-
because of the slower equilibration of creatinine com-priate for patients receiving intermittent peritoneal dial-
pared to urea. For the same reason, during APD at night,ysis? If, as postulated by the peak concentration
when exchanges dwell in the peritoneal cavity over shorthypothesis, control of the peak urea nitrogen concentra-
periods, urea clearance targets are easier to achieve thantion is critical in preventing uremic toxicity, then inter-
creatinine targets [36]. The use of a different normalizingmittent peritoneal dialysis requires a higher dose to
constant (that is, V for urea and body surface area formaintain the peak concentration below the levels
creatinine) is an additional reason for the discrepancyachieved in CAPD. The DOQI recommendation for noc-
between KT/V and WCC. Thus for an obese patient, anturnal intermittent peritoneal dialysis is 2.2 per week for
overestimation of V can result in a low KT/V. BodyKT/V and 66 liters/1.73 m2 for WCC [13].
weight changes have less effect on BSA and thereforeLet’s look for a moment at creatinine clearance tar-
gets. Using retrospective comparisons, Boen et al recom- on normalized WCC [37].
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Table 2. Formulas calculating dietary protein intake from urea tained a small error (corrected by Dr. J. Bergstro¨m, per-
levels in CAPD patients
sonal communication). Kopple’s formula, which also is
Randerson [43] PNA (g/day) 5 810.15 UA (mM/day)a founded on balance studies, gives values between those
Bergstro¨m [44] PNA (g/day) 5 1910.2134 UA (mM/day)b obtained with the Randerson and Bergstro¨m formulasKopple [46] PNA (g/day) 5 6.810.97 UNA (g/day)c
[46]. Although the Randerson formula has been the pre-
a PNA, protein equivalent of nitrogen appearance; UA, urea in dialysate and
ferred method to date, I agree with the conclusion ofurine
b Formula cited here is Dr. Bergstro¨m’s revision [45] of the original version [44] Mandolfo et al [47] that the Bergstro¨m formula, which
c UNA, urea nitrogen appearance
is based on balance studies, should become the standard
method.
Because larger patients should have a higher protein
intake than smaller patients, it has been a common prac-Nutrition
tice to adjust the PNA to the patient’s body weight toThe observation that the dose of dialysis is related to
create a normalized PNA (NPNA) that can be used forthe NPNA (an index of the patient’s protein intake and
comparison and correlation purposes. However, this nor-appetite) led Lindsay and Spanner to suggest that in
malization process creates significant problems becausehemodialysis, good nutritional status, as indicated by a
clinicians have not agreed what weight to use for thisprotein equivalent of nitrogen appearance (PNA) . 1
calculation. None of the various proposals, or for thatg/day, is the major determinant of low morbidity [38];
matter the nomalization concept itself, has been clinicallyhowever, good nutrition cannot be obtained without ade-
validated [5, 48]. Thus, if the present, actual body weightquate dialysis, as indicated by a KT/V . 1.0 per hemodi-
is used, normalization creates a mathematical bias in
alysis session. One can assess nutrition by clinical evalua-
obese patients, in whom the NPNA is underestimated,
tion, dietary history, anthropometric measurements, and
and in the wasted individual in whom NPNA is overesti-
various biophysical and biochemical methods. Among
mated. Alternatives that have been suggested are: (1)
the anthropometric indices, one of the simplest and most using standard body weight (5V/0.58), where V is calcu-
useful is subjective global assessment, which includes lated by the Watson formula, which takes into account
four items: weight loss in the previous six months, an- age, gender, height, and weight and (2) desirable body
orexia, loss of subcutaneous fat, and assessment of mus- weight, which is the midpoint of the range associated with
cle wasting. According to this method, patients are char- greatest longevity for normal individuals of the same age
acterized as well nourished, mildly malnourished, or range, gender, and skeletal frame as the patient. These
severely malnourished. This method has been validated weights are published in the actuarial tables of the Met-
in CAPD patients [39]. ropolitan Life Insurance Company. Although normaliza-
The PNA. In addition to providing the KT/V, urea tion using these techniques provides higher values of
kinetic modeling can be used to calculate daily protein NPNA for the obese and lower for the wasted, none of
intake based on the amount of urea excreted (urea ap- these alternatives has been validated in any published
pearance), assuming that the patient is in neutral bal- studies; hence we should test their usefulness in prospec-
ance. The protein intake, thus calculated, used to be tive studies. Canaud et al recently proposed normalizing
called the protein catabolic rate. However, since the ac- the PNA to the lean body mass, because muscle mass
tual catabolic rate is 5 to 6 times that of daily protein constitutes the major reserve of endogenous proteins
intake [40], and we do not know whether the patient is and nitrogen fuel within the body, thus establishing a
catabolic, a better term is “protein equivalent of nitrogen link between PNA and lean body mass [49].
appearance.” Some investigators have found a high cor- The NPNA is an important reflection of protein intake
relation between actual dietary protein intake, estimated but, measured by various formulas, the correlation coef-
by food records, and the PNA [41]; others have noticed ficient between dietary protein intake and NPNA is about
a marked discrepancy between the two [42]. 0.6, which is less than impressive [43, 50]. In CAPD, in
Table 2 shows the various formulas proposed for the contrast to hemodialysis, in which NPNA is an important
calculation of protein intake for urea appearance. The predictor of outcome [14], NPNA frequently correlates
Randerson equation, derived from hemodialysis pa- with technique failure but not with other outcomes [20–
tients, has been validated in CAPD patients [43]; to this 24, 48, 50, 51]. The PNA is inversely related to age, being
result, one should add the value of estimated protein lower in older patients [52] and in diabetics. In Selgas’
losses. Bergstro¨m’s formula, based on nitrogen balance study, patients with NPNA . 1 g/kg/day had a lower
data among CAPD patients, takes into account the rate of hospitalization compared to those with a value ,
greater non-urea nitrogen losses in peritoneal dialysis 1.0 g/kg/day [32]. Harty et al have questioned the validity
[44] and therefore yields significantly higher values than of adjusting PNA [48] in light of the failure of NPNA
the Randerson formula. The formula presented here [45] to reflect conventional parameters of nutrition in cross-
sectional analyses of hemodialysis [52] and CAPD pa-differs from that in the original publication, which con-
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Table 3. Shared components are responsible for the correlationtients [24]. Their study of 147 CAPD patients showed
between KT/V and NPNA (mathematical coupling)a
no correlation between NPNA and measures of nutrition
KT/V NPNAor measures of body composition and disclosed no sig-
nificant differences between well-nourished and mal- Dialysate urea
Plasma urea
3 dialysate vol. Dialysate urea 3 dialysate vol.
nourished patients. Until a proven method for normaliz-
ing PNA is developed and validated, the clinician should V (Const 3 wt) V/0.58 (wt)
be aware of the risks of normalization as currently ap- a From Ref. 35
plied with regard to obese and wasted patients.
Dialysis dose and nutrition. The precise relationship
between adequacy of dialysis and nutritional status has
remained elusive and is a continuing subject of debate suggests that increasing the dialysis dose has a more
salutary effect in CAPD. Bergstro¨m et al, who analyzed[53]. Uremia commonly leads to anorexia, which gener-
ally is thought to be due to the accumulation of toxic pooled data of balanced studies—their own and those
of Blumenkrantz et al [59]—found a good correlationcompounds that inhibit appetite [44, 54]. In elegant ex-
periments in rats, Bergstro¨m and colleagues demonstrated between NPNA and KT/V in both hemodialysis and
CAPD but a steeper slope in CAPD [44].that uremic toxins with a molecular weight between 1.0
and 1.5 kD (extracted from both uremic serum and nor- The finding of a steeper slope for CAPD than hemodi-
alysis supports the peak concentration hypothesis [15]mal urine) suppress appetite [55]; when these molecules
were injected intraperitoneally into normal rats, their and the role of middle molecules as a uremic toxin.
Bergstro¨m and Lindholm also suggested that the releasefood intake decreased in a dose-related fashion. The
CANUSA study recently confirmed that anorectic ure- of catabolic cytokines, the development of acidosis be-
tween dialysis sessions, and the loss of amino acids duringmic patients who reach end-stage disease commonly re-
gain their appetite after initiation of dialysis [53]. This hemodialysis has an even greater impact on catabolism
than do protein losses in CAPD patients [60]. Further-observation suggests that uremic toxins that cause an-
orexia are removed by dialysis. It also is common clinical more, glucose absorption can have a protein-sparing ef-
fect [35, 60], although Bergstro¨m and Lindholm couldexperience that inadequately dialyzed patients have a
poor appetite and occasionally a special aversion to meat, find no relationship between the amount of glucose ab-
sorbed and the protein or energy intake, nor any differ-and that sometimes their appetite improves when the
dialysis prescription is appropriately modified [56]. On ence in protein/energy intakes, whether the abdomen
was empty or filled with dialysis solution.the other hand, well-dialyzed patients feel good and eat
well. For years now, but especially for the last 5 to 10 Harty and colleagues challenged the validity of this
relationship [35, 48]. First they reported that, althoughyears, investigators have attempted to validate these clin-
ical impressions by establishing a relationship between they observed a correlation between KT/V and NPNA,
this relationship did not exist between unadjusted PNAdialysis dose and the amount of dietary protein intake
[57]. Establishing such a relationship would be of particu- and KT/V. Instead they found only a weak correlation
between unadjusted PNA and unadjusted urea clearancelar importance because it would unify two factors, dial-
ysis dose and nutritional status, both of which are strong (KT). Paradoxically, malnourished patients had the high-
est values for normalized urea clearances (KT/V), pro-predictors of outcome. Such a relationship would give
nutrition a central role and thus would have important ducing a significant but inverse correlation between KT/V
and lean body mass [35]. This paradox could be partiallytherapeutic implications, because one could improve nu-
trition by increasing dialysis dose. resolved when, instead of normalizing to actual weight,
the clearance was normalized to ideal body weight ob-In 1989 Lindsay and Spanner established the relation-
ship between KT/V and NPNA for hemodialysis and tained from the National Health and Nutrition Examina-
tion Survey (NHANES) tables; then a weakly positiveCAPD patients. They observed that the slope of the
relationship was lower among CAPD than hemodialysis correlation emerged between KT/V and some nutritional
parameters. Interestingly, in the latter case, the contribu-patients. Among hemodialysis patients dialyzed with a
cellulosic membrane, the mean slope was 0.61, whereas tion of residual renal function, not the level of peritoneal
clearance, was responsible for the positive correlation.among those dialyzed with polyacrylonitrile membranes,
the slope was higher (1.08) [38]. Subsequently Lysaght These observations led Harty and colleagues to argue
forcefully and convincingly that this relationship is con-et al [17] and other investigators [20, 58] confirmed the
positive relationship between NPNA and KT/V in CAPD ceptually and mathematically flawed [35]. They pointed
out that, because KT/V and NPNA share three compo-patients. Contrary to the findings of Lindsay and Spanner
[38], other investigators found that the slope between nents (Table 3), any relationship between the two must
be due, in part, to mathematical coupling. They supportedKT/V and NPNA is higher (1.5 to 2.0 3) in CAPD patients
than in hemodialysis patients [17, 58]. This observation this contention further when they showed that randomly
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protein intake was measured. (4) A dissociation in the
relationship occurs when PNA is increased or decreased
by changes in protein intake [66]. (5) KT/V and NPNA
are more closely related in diabetics than in non-diabet-
ics [67]. More than any other evidence, however, longitu-
dinal studies support a physiologic basis for the relation-
ship between NPNA and KT/V. Such studies are not
affected by a spurious correlation, because an increase
in urea generation due to an increase in KT/V would
provide unequivocal evidence of increased production
and removal of urea nitrogen. Under these circum-
stances, an increase in NPNA in the absence of weight
Fig. 3. Correlation between KT/V and NPNA levels off over a certain loss or acute stress could result only from an increase in
level of KT/V (P , 0.005). (Courtesy of Dr. Peter Blake.) protein intake [68]. Of course the strongest support for
the influence of dialysis dose on nutritional status would
be a correlation between changes in dialysis dose and
changes in various nutritional estimates, such as subjec-generated KT/Vs and NPNAs were strongly correlated
tive global assessment (SGA) and lean body mass (orwith r values between 0.6 and 0.74. In 1996 Uehlinger
serum albumin).showed that this correlation between randomly generated
Table 4 provides a summary of several prospectivenumbers is apparent only when V shows a big variation;
longitudinal studies on the effect of KT/V on NPNA andit is completely absent when V is constant [61]. This sug-
other nutritional parameters. Lindsay et al, who increasedgests that it is not the normalization with a common com-
KT/V from 0.59 to 0.9 among eight CAPD patients forponent per se that introduces the statistical artifact, but
three months, observed an improvement in NPNA by
rather the variation of the component. The lack of a strong
0.282 g/kg/day [69]. Heimburger and colleagues increased
relationship between KT/V urea and other formal mea- weekly KT/V from 1.53 to 1.89 in 19 CAPD patients over
sures of nutrition contrasts significantly with the strong three months and observed an increase in NPNA and
correlation between KT/V and NPNA, and supports the an increase in serum albumin from 2.91 6 0.41 to 3.05 6
view that, in large part, the correlation (between KT/V 0.43 g/dl, which was not statistically significant [70]. After
and NPNA) is mathematical. I should emphasize, how- an increase in weekly KT/V in 17 CAPD patients from
ever, that these findings do not negate the existence 1.44 to 1.78 for one month, Burkart et al observed an
of a physiologic relationship between dialysis dose and increase in NPNA from 0.616 to 0.695 g/kg/day (P ,
protein intake; Harty et al also accept this possibility 0.05) and in serum albumin from 3.5 (mean of 3 monthly
[25]. Mathematical coupling increases the magnitude of albumin values prior to change) to 3.69 g/dl (3 monthly
such a correlation. Unfortunately we have no simple albumin values after change) (P , 0.035) [71]. Uribarri
statistical procedure to test whether an observed rela- and coworkers increased weekly KT/V from 1.85 to 2.3
tionship exceeds the purely statistical association [61]. in 23 patients for 6 months and observed an increase in
The following observations support the existence of a serum albumin from 3.55 to 3.83 g/dl, but not of NPNA
physiologic relationship between NPNA and KT/V: (1) (0.98 to 1.0 g/kg/day) [72]. By increasing KT/V by 25%
In 1993 Blake et al asserted that the relationship between in 40 malnourished CAPD patients, Davies et al halted
KT/V and NPNA is not linear but flattens out after a or partially reversed their nutritional decline (improve-
weekly KT/V of 1.83 [62] (Fig. 3). Nolph et al [63] and ment in lean body mass), but it took at least 6 months
Ronco et al [7, 64] subsequently confirmed this finding. to see the benefit of intervention [73]. Lynn et al in-
These observations suggest that there is a dialysis dose creased KT/V among 10 patients from the previously
above which protein intake is dialysis-dose-independent accepted targets of .1.6 to a new KT/V of 2.81 [74].
and instead will depend on the patient’s dietary choices They demonstrated significant increases in NPNA levels
[7, 63, 65]. Below this point, however, protein intake of .1.0 g/kg/day in 9 of 10 patients [74]. These patients
should strongly be correlated with dialysis dose. This reverted to baseline NPNA levels four weeks after re-
observation probably explains the lack of correlation turning to their original dialysis prescription. Williams
that some investigators have observed between NPNA et al prospectively studied 10 patients after change of
and KT/V in well-dialyzed patients. (2) Differences exist KT/V from 1.37 to 1.68 for three months. Neither NPNA
between the slopes in hemodialysis and CAPD and the nor serum albumin changed significantly [75]. Harty et
difference in the slope of patients dialyzed with cellulosic al increased weekly KT/V from 1.5 to 1.8 in 33 patients
and those with polyacrylonitrile membranes [38, 44]. (3) for 3 months but could show no increase in NPNA [76].
Prospectively, Malhotra et al increased the KT/V fromThis relationship was confirmed in balance studies when
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Table 4. Summary of prospective longitudinal studies of the effect of changes in KT/V on NPNA, serum albumin,
or other nutritional parameters
KT/V Duration Changes in NPNA or DNPNP Change in mean serum albumin
initial/final months N g/kg/day before/after
Lindsay et al [69] 0.59/0.9 3 8 0.282
Heimburger et al [70] 1.53/1.89 3 19 0.81/0.87 2.91/3.05 g/dl
Burkart et al [71] 1.44/1.78 1 17 0.616/0.695a 3.5/3.7 g/dl
Uribarri et al [72] 1.85/2.3 6 23 0.98/1.0 3.5/3.8 g/dl
Davies et al [73] D↑25% .6 40 0.86/0.91 Improvement in LBMb
Lynn [74] .1.6/2.81 10 Sign. incr. in PNA in 9/10
patients .1.0 g/kg/day
Williams [75] 1.37/1.68 3 10 0.88/0.89
Harty et al [76] 1.5/1.8 3 33 No changes
Malhotra et al [77] 1.4/2.1 8 65 37 0.74/0.96a No changes in mean serum albumin
3.4/3.3 (decreased in 18, increased
in 15, unchanged in 4)
a P , 0.05
b LBM, lean body mass; PNA, protein equivalent of nitrogen appearance
1.4 to 2.1 in 37 patients [77]. Appetite improved and trition of dialysis patients is metabolic acidosis which,
even when slight, can increase the catabolism of branch-NPNA increased from 0.74 to 0.96 g/kg/day, but the mean
serum albumin of the group did not change. In individual chain amino acids (valine, leucine, and isoleucine) and
lead to valine depletion that limits protein synthesis. Apatients, however, the serum albumin decreased in 18 and
increased in 15; those in whom serum albumin increased portion of this uremic malnutrition would respond to
increases in small-solute clearance and correction of aci-were younger and had a higher dietary protein intake
and BUN after the increase in dialysis dose. dosis, but a further portion might be related more to
defective protein anabolism, secondary to dysfunctionObviously these results are inconclusive. Analysis of
the CANUSA results provides the best evidence of the of the growth hormone/IGF-1 endocrine axis. This latter
portion might respond better to the administration ofeffect of urea clearance on nutritional parameters [53].
Thus, after initiation of dialysis, weekly total KT/V in- agents such as rHGH or even anabolic steroids than to
increases in dialytic dose [78].creased by 1.5 and weekly total CCr by 35.6 liters/1.73 m2.
During the first six months, there was improvement in The second major type of malnutrition, which might
be termed comorbid malnutrition, that is, secondary tothe mean subjective global assessment, lean body mass,
diabetes, heart failure, chronic inflammation, malignancy,and percentage of lean body mass. The subjective global
etc., would not respond to alterations in dialytic dose orassessment increased by 0.72 U (P , 0.001), the lean
even protein intake. Infections are important stimulantsbody mass by 1.6 kg (P , 0.001), and the percentage
of protein catabolism; these, combined with increasedof lean body mass by 1.4% (P 5 0.01). However, no
protein losses, which vary between 5 and 15 g/day andstatistically significant changes were noted in serum albu-
increase significantly with peritonitis, can lead to malnu-min, PCR, or normalized PCR. This improvement in
trition and hypoalbuminemia in CAPD patients [60].several unrelated markers of nutritional status during
Malnutrition in individual patients can be of one typethe first six months of CAPD supports the contention
or the other or even a mix of these [50].that improved toxin clearance contributes to improved
nutritional status [53]. However, the correlations were
Fluid/volume controlweak, so non-dialysis factors such as comorbidity likely
have an important influence on nutritional status. Serum Low urea clearance and malnutrition/hypoalbumi-
nemia increase the risk of death, while cardiovascularalbumin levels, although not influenced by dialysis dose,
remained a strong predictor of outcome. This observa- deaths are the main cause of mortality in CAPD patients.
Therefore, it is logical for us to speculate that low KT/Vtion suggests that serum albumin level is influenced more
strongly by non-nutritional factors, such as comorbidity and malnutrition increase the risk of death from cardio-
vascular causes. How might low KT/V values and malnu-and peritoneal albumin losses.
Malnutrition. Malnutrition has a complex pathogene- trition modify cardiovascular risk? Harty et al suggest
that insufficient clearance returns the patient to the pre-sis and does not depend only on adequacy of dialysis.
Hence two major types (or causes) of malnutrition fre- dialysis uremic milieu and thus increases the likelihood
of cardiac dysfunction [25]. However, another possiblequently occur together in dialysis patients (Fig. 4). The
first, uremic malnutrition, is related to the uremic disor- relationship ties dialysis adequacy targets and cardiovas-
cular mortality: the relationship between fluid overloadder per se [50]. Another contributing factor in the malnu-
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Fig. 4. Various pathogenetic mechanisms of
malnutrition in CAPD patients. (From Ref. 50.)
and hypertension, which leads to atherosclerosis and left- albumin and low lean body mass, but we do not know
whether (in these patients) these indices have the sameventricular hypertrophy [79]. Thus, volume overload can
directly affect cardiovascular mortality through the de- predictive value as if they were the result of malnutrition.
Harty et al found no evidence of excess malnutritionvelopment of hypertension and left-ventricular hypertro-
phy [80], which in turn identify the dialysis patients who [assessed by anthropometric and serum protein values
and subjective global assessment (SGA) categorization,are at risk of sudden death, stroke, and congestive heart
failure [81, 82]. Fluid volume control becomes more dif- composite nutritional index] in high transporters [35],
whereas Nolph and colleagues did [88]. Nolph et al rec-ficult when anuria supervenes two to four years after the
initiation of CAPD. By that time, peritoneal ultrafiltra- ommended that high transporters may warrant increased
clearance and protein intake targets. An alternative ex-tion has declined in as many as 30% of CAPD patients,
who then develop fluid retention [83, 84]. Most CAPD planation for the increased mortality rate among high
transporters is the low ultrafiltration that leads to fluidpatients suffer from fluid overload, as indicated by cen-
tral wedge pressure measurements and measurements overload, which (when chronic) can lead to left-ventricu-
lar hypertrophy and cardiovascular disease [80, 90]. Weof plasma cGMP levels—a marker of the hydration state
[18, 85, 86]. Charra et al have achieved success in manag- do not know the best treatment for high transporters,
but volume control likely is important. High transportersing hypertension through control of extracellular fluid
volume [3]; they believe this approach is superior to thus are candidates for nocturnal intermittent PD with
short exchanges. This technique leads to better ultrafil-pharmacologic control. Also, they have noted that even
small increases in fluid volume increase the patient’s tration, slightly reduced protein losses, lower glucose
absorption, and better protein intake [88]. Whether con-resistance to antihypertensive medication.
Patients have been classified into four groups on the version to NIPD will lead to higher survival rates is not
known. In an outstanding recent review, Bergstro¨m andbasis of peritoneal transport: low (L), low average (LA),
Lindholm described a hypothesis integrating malnutri-high average (HA), and high transporters (HI) [87]. The
tion, cardiac disease, and mortality [91].high transporters (D/Pcreat . 0.80) need special atten-
tion from the nephrologist. These patients have signifi-
Improving KT/V in underdialyzed patientscantly lower serum albumin levels and NPNA, and lower
body mass than do the other groups [88]. The low albu- The need for an increase in KT/V becomes critical
when the patient becomes anuric; special attention mustmin level probably is the result of increased protein
losses across the peritoneum. Also, these patients have be paid to those of large body size, especially patients
who (with respect to peritoneal permeability) are lowa low NPNA, disproportionate to the level of KT/V,
which might be due to increased use of high-glucose transporters. Before one institutes a change in the dial-
ysis prescription, one must ensure that the patient issolutions that, in turn, decrease appetite.
In the CANUSA study, the two-year patient survival compliant with the dialysis instructions. Blake et al noted
that patients ignore 20% to 30% of all prescribed changesprobabilities were 91%, 80%, 72%, and 68% for L, LA,
HA, and HI, respectively [89]. All groups have low serum in their dialysis treatment plan, and usually the staff
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cannot detect this [92]. Furthermore, some patients run clearances. (4) The longer a patient stays on automated
peritoneal dialysis at night, the better the clearance. (5)the risk of reducing the effective exchange volume when
they flush larger volumes (than they have been in- Increasing the number of exchanges over a given period
does not always increase clearances and, in patients withstructed) during the flush of the lines, either because of
ignorance or because they are in a hurry to finish the low peritoneal transport, can even decrease clearances.
(6) Many large patients require two daytime exchanges.exchange. Noncompliance that can lead to inadequate
dialysis appears to be more frequent in the US than in (7) Tidal PD, in which the peritoneal cavity is not drained
completely but a volume of 1.0 to 1.5 liters is left inCanada, and this factor might account, at least in part,
for the observed difference in the mortality rate between the peritoneal cavity between exchanges, theoretically
is better but has been somewhat disappointing in practicethe two countries [92].
Of the various ways of enhancing peritoneal dialysis, [97]. In trying to optimize dialysis, we should not forget
that whatever measures we recommend should be com-increasing the exchange volume is the most critical, least
expensive, and least intrusive into the patient’s life [93]. patible with costs and the patient’s time availability and
quality of life. As Nolph said, our goal must be to offerSchoenfeld et al found that clearance of small molecules
increases linearly with intraperitoneal volumes [94]. Ke- dialysis so that our patients will live comfortably rather
than merely live so they can do dialysis [98].shaviah et al confirmed this observation and found that
the fill volumes needed to achieve peak clearance in- Although the topic of my discussion has been adequacy
of CAPD, let me briefly comment on the utility of thiscreased with increasing body surface area: approximately
2.5 liters for a person of average size and 3.0 to 3.5 concept in patients with severe, chronic renal failure. If
maintaining targets of small-solute clearance and goodliters for an approximate BSA $ 2 m2 [95]. The net
ultrafiltration is increased in response to higher volumes nutritional status is critical for the patient on dialysis, it is
reasonable to assume that these same targets, especiallybecause of better maintenance of the dialysate-to-plasma
glucose concentration gradient. Concerns about the use those established for a continuous therapy like CAPD,
are also critical for the patient with declining renal func-of increased volume include risk of hernia, increased
glucose absorption from the larger intraperitoneal vol- tion. In this case dialysis should start when residual renal
function falls below the targets. This view is supportedume, increased costs, and diminished quality of life be-
cause of the extra time required for dialysis, which leads by the observation that initial KT/V is inversely related
to hospital admission rates, number of hospitalizationto decreased patient acceptance of the procedure [28].
Finally, urea and creatinine clearances were significantly days [99], and patient survival [53, 100]. Similarly, nutri-
tional status at the start of dialysis is predictive of long-higher (up to 1.73) in the supine than the upright posi-
tion [94, 96]. term outcome [23]. The DOQI group recommends that
patients be advised to initiate some form of dialysis whenIn the majority of anuric CAPD patients, the “stan-
dard” CAPD protocol of four two-liter exchanges per the weekly renal KT/V urea falls below 2.0 unless the
patient’s edema-free weight is stable, NPNA is aboveday is not adequate to achieve the recommended small-
solute targets. Accordingly, the physician should modify 0.8 kg/day, and the patient has no clinical symptoms.
One has to balance the benefits of this approach againstthe protocol, taking into account the patient’s size and
peritoneal permeability. Anuric patients who want to the patient’s desire to postpone dialysis as long as possi-
ble, and the increased costs and potential risks of dialysis.remain on CAPD require a fifth exchange that can be
accomplished in the night with the “night exchanger” Prospective, controlled studies should establish the po-
tential benefits of the early start before it is widely ac-Quantumt (Baxter). In most cases, however, the patient’s
dialysis treatment will have to be converted to automated cepted and practiced.
Before I conclude, let me make a comment on theperitoneal dialysis, that is, either continuous cyclic peri-
toneal dialysis (CCPD), with two liters left in the perito- standardization of guidelines. There is no doubt that
the practice of peritoneal dialysis varies among centersneal cavity during the daytime or with one or two ex-
changes during the daytime (enhanced CCPD). within a country and also among various countries. In a
recent survey, Ganz et al revealed a significant variationCertain principles should govern the prescription of
automated peritoneal dialysis. (1) The target for KT/V in dialysis practice and, most important, in various labo-
ratory parameters (that is, hemogloblin, albumin, PTH)on intermittent treatments should be higher than that
for patients on CAPD. The recent DOQI group recom- among various centers in British Columbia [101]. The
DOQI guidelines on adequacy of peritoneal dialysis rep-mended a KT/V of 2.2 and creatinine clearance of 66
liters/week/1.73 m2. (2) If the creatinine clearance target resent the first attempt to develop an approach to de-
crease discordance among centers and improve patientis maintained when one is switching from CAPD to NIPD,
urea clearance targets automatically will be achieved. outcome. I consider this important effort only the begin-
ning, and I envision regular revisions based on new evi-(3) The same quantity of the total dialysate delivered
in larger volumes of fewer exchanges produces better dence in the years to come.
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QUESTIONS AND ANSWERS fect serum albumin levels. There is no doubt that, in
large series, CAPD patients have lower mean serumDr. Nicolaos E. Madias (Chief, Division of Nephrol-
albumin levels than do hemodialysis patients. However,ogy, New England Medical Center, Boston, Massachu-
low serum albumin does not always reflect nutritionalsetts): You addressed the paradox that patients maintained
status. In an excellent study, Kaysen and Schoenfeldon peritoneal dialysis have a life expectancy similar to
showed that CAPD patients have reduced catabolismthose maintained on hemodialysis despite markedly lower
and increased anabolism and therefore their total albu-KT/V values, and you accounted for this paradox by in-
min mass does not differ from that in controls [102].voking the peak concentration hypothesis. Although at-
According to these authors, the main reason for hypoal-tractive, this is merely a hypothesis and, after all, there
buminemia in CAPD is an increase in the volume ofare ample differences between these two modalities.
distribution of the albumin mass. It is almost universallyCould you please offer other potential explanations for
accepted that, both in hemodialysis and peritoneal dial-this phenomenon?
ysis, hypoalbuminemia is a strong predictor of mortalityDr. Oreopoulos: Other possible explanations include
[20, 33, 40]. However, it seems that the level of albuminthe stable hydration and blood chemistry in CAPD pa-
does not have the same effect on outcome in peritonealtients, the high clearance of large molecules, a better
dialysis as in hemodialysis. Thus, whereas in hemodialy-preservation of residual renal function, and a less cata-
sis the relative risk (RR) of death was significantly in-bolic environment. The weight of hemodialysis patients
creased when serum albumin was 3.0 to 3.5 g/dl, in CAPDoften fluctuates by 3 to 6 kg between dialyses, while that
such an increase in mortality appeared when the albuminof CAPD patients remains constant. Their biochemical
concentration was less than 3.0 g/dl [103]. The strongestvalues increase to a maximum before hemodialysis and
single predictor of low serum albumin is high peritonealdecrease dramatically at its end. On the contrary, the
permeability that leads to low albumin levels eitherweight and blood chemistry of CAPD patients do not
through the increased protein (albumin) losses or throughfluctuate. The CAPD patients definitely have less acido-
overhydration and hemodilution of serum albumin [104].
sis than do the hemodialysis patients; serum bicarbonate
Recently Han et al [105] and Yeun and Kaysen [106]
levels in the former group range from about 24 to 28 showed that serum albumin is strongly influenced by
mm/liter. In hemodialysis, the interaction between blood its role as an inverse acute-phase reactant; both groups
and the dialysis membrane produces various cytokines hypothesized that the same patterns of cytokine activa-
that can be nephrotoxic. Finally, in CAPD, residual renal tion associated with acute-phase reaction also could in-
function reportedly declines at a much slower rate than crease vascular and thus peritoneal permeability. Addi-
it does in patients treated by hemodialysis. All these tional factors that can lead to hypoalbuminemia are
differences taken together might explain the similar mor- diabetes and cardiovascular disease, which by themselves
tality rate between the two treatment modalities, despite lead to increased mortality rates. In patients with these
lower clearances of small molecules with CAPD. disorders, hypoalbuminemia is an index of the severity of
Dr. Madias: Why does residual renal function decline the disease and not necessarily of malnutrition. Finally, I
at a slower rate in CAPD than it does in hemodialysis? would like to stress that the method of measuring albu-
Dr. Oreopoulos: There are various potential reasons. min can affect serum albumin levels; the most frequently
In addition to the release of cytokines during the hemodi- used method—the colorimetric test using Bromcresol
alysis procedure, CAPD patients have a lower protein green—markedly overestimates albumin levels, whereas
intake than do hemodialysis patients. This difference in the Bromcresol purple method gives values that slightly
protein intake is accentuated further by peritoneal losses underestimate the true level compared with the “gold
of protein during CAPD. Furthermore, CAPD patients standard,” which is the nephelometry measurement [40].
are in a continuous state of fluid expansion when com- Because albumin is affected by so many factors, it is not
pared with hemodialysis patients [85, 86]. Finally, CAPD as good an index of nutrition as are other nutritional
patients do not experience the decreases in blood pres- parameters.
sure that are so frequent during hemodialysis. These Dr. Madias: Would you please comment on the effect
factors taken together might contribute to the better of intraperitoneal amino acids on the level of malnutri-
maintenance of residual renal function in CAPD patients. tion in general, and on serum albumin in particular?
Dr. Madias: You did not say much about hypoalbumi- Dr. Oreopoulos: Very early in the history of CAPD,
nemia in peritoneal dialysis patients. Is it as ominous a circa 1978, when we recognized that malnutrition was
predictor of mortality in peritoneal dialysis as it is in an early complication of CAPD, we suggested replacing
hemodialysis? Is it related to underdialysis? glucose as an osmotic agent with amino acids [107]. In
Dr. Oreopoulos: I spoke chiefly about other nutri- this way we could dialyze the patients with amino acid
tional indices of malnutrition and did not discuss albumin solutions and simultaneously replace protein losses. Al-
though this was a great idea, it took the industry 15 yearslevels because many factors other than malnutrition af-
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to come up with commercial amino-acid-containing solu- months, when total weekly creatinine clearance did not
change, the nutritional parameters did not change either.tions. Such solutions are not yet available in the US
but have been used for the last 4 to 5 years in Europe Dr. Madias: Mathematical bias notwithstanding, you
indicated that in two different populations the relation-(Nutrinealt with 1.1% amino acids, Baxter). Dialysis
with one or two daily exchanges of Nutrineal for as long ship between KT/V and NPNA was steeper in CAPD
than in hemodialysis. What might be the basis for thisas four weeks produces a positive nitrogen balance [108].
However, serum albumin increased only minimally. Sub- difference?
Dr. Oreopoulos: This observation supports the peaksequently, in a large study 71 patients received one to
two exchanges with Nutrineal for three months and were concentration hypothesis in that the CAPD patients have
constant biochemical values. An intermittent therapycompared with 63 patients who were dialyzed with stan-
dard solutions [109]. Even though the differences be- requires a higher weekly KT/V to maintain the BUN
peaks at or below the steady BUN of CAPD, assumingtween the two groups were not great, a subgroup of
malnourished patients treated with amino acids showed a similar protein intake and urea excretion rates. Thus,
if elevated BUN peaks are associated with appetite sup-an increase in serum albumin and improvement in other
nutritional parameters. Thus I believe that the use of pression (directly or indirectly), a higher weekly KT/V
would be required with an intermittent therapy to yieldamino-acid-containing solutions has a place in severely
malnourished patients on CAPD. a given NPNA. The observation also emphasizes the
importance of toxic substances of middle or large molec-Dr. John T. Harrington (Dean, Tufts University
School of Medicine, Boston, Massachusetts): Dimitrios, ular weight that can be removed more effectively by
peritoneal dialysis than by hemodialysis.thank you for a wonderful review. In your comments
about Peter Blake’s study, did you say that patients with Dr. Geetha Narayan (Division of Nephrology, St.
Elizabeth’s Medical Center, Brighton, Massachusetts): Ia KT/V less than 1.5 had a good outcome? That finding
is at variance with other observations. Could you tell us believe that you said that both the well-nourished and
the malnourished groups had the same NPNA when ad-more about your interpretation of Blake’s study?
Dr. Oreopoulos: No, I did not say that, John. Indeed, justed for standardized weight. Could you explain that?
Dr. Oreopoulos: Harty et al compared a group ofI might not have been clear about that point. Blake
found that mortality increases after the KT/V falls below patients who were well nourished and another group of
malnourished patients (who had lost weight) and found,1.5. He could not find a difference in mortality with high
levels, however. Actually, what he found makes sense; if as you would expect, that the calculated daily PNA—that
is, an expression of the daily protein intake expressedyou keep decreasing dialysis dose, eventually the patients
will suffer increased morbidity and mortality due to ure- in grams per day—was higher in the well-nourished
group than in the malnourished group [48]. However,mia. However, Blake’s cut-off point was lower than that
in other studies. All other studies showed increased mor- when they normalized the PNA with the patients’ pres-
ent weight (NPNA, that is, g/kg/day), they found thetality if KT/V falls below 1.8 to 2.0. In Blake’s series,
the cut-off point was below 1.5. The difference between reverse; that is, the NPNA was higher in the malnour-
ished patients, who had lost body weight, than in thehis and other studies might be due to the fact that he
did not measure KT/V but merely calculated it; yet, when well-nourished ones. This is a misleading paradox.
Dr. Ajay K. Singh (Director of Clinical Nephrology,he re-analyzed the data using the measured KT/V, his
original findings remained unchanged. The most likely Brigham & Women’s Hospital, Boston, Massachusetts):
A consensus appears to be emerging in the managementexplanation is that the number of patients followed was
too small for Blake to detect the benefits of higher clear- of ESRD patients that hemodialysis rather than perito-
neal dialysis is the preferable dialytic option for largerances on mortality.
Dr. Ronald D. Perrone (Division of Nephrology, patients. In a recent study by your group addressing this
issue [110], I believe you compared patients weighing 80New England Medical Center): You spoke of the mathe-
matical relationship between KT/V and NPNA because kg or more with a group whose body weight was 60 to
80 kg. Could you elaborate on the findings in that studyof the shared variables. Have any good studies looked
at the relationship between weekly creatinine clearance, and tell us whether you agree with this emerging con-
sensus?an independent measure of adequacy, and NPNA?
Dr. Oreopoulos: The only study I can quote is the Dr. Oreopoulos: In that study, we compared the sur-
vival of CAPD patients whose weight was over 80 kgCANUSA study [23]. During the first six months, be-
cause of the initiation of dialysis, total weekly creatinine with those whose weight was less than 60 kg and found
no difference in mortality rate between the two groupsclearances rose by approximately 30 to 40 liters (pro-
vided by dialysis), and there was an increase in the sub- [110]. Unfortunately, we did not have data on their KT/V,
but you would expect, would you not, that because thejective global assessment and in lean body mass but not
in serum albumin or NPNA. During the subsequent 12 daily dialysis volumes were similar in the two groups,
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there probably were differences in their KT/Vs. These ual renal function have adequate KT/V and weekly creat-
inine clearance. After all, 1 ml of GFR provides 10 litersfindings are similar to those of Kopple et al, who found
that overweight hemodialysis patients, despite lower per- of weekly creatinine clearance and 0.25 of weekly KT/V.
When the creatinine clearance falls below 1 ml/min orcent urea reduction rates, had better survival rates [111].
Heavier patients might have an advantage in that they if the 24-hour urine volume drops below 100 ml/day on
at least two successive occasions, we adjust the dialysisare better nourished to begin with, and this might com-
pensate for the fact that they receive relatively less dial- dose and repeat the adequacy test. I want to emphasize
again the importance of following up the residual renalysis. Interestingly, in our study, we found a significantly
higher mortality rate in both groups among those pa- function.
Dr. Singh: Peter Blake presented some attractive datatients who had lost weight. This brings us back to the
central role of nutrition. Another explanation for our on compliance with the peritoneal dialysis prescription
when he visited Boston about a year ago. In light offindings would be that the patients with the higher body
weights might have had better residual renal function. I the disturbing data on mortality of peritoneal dialysis
patients in the United States, it seems crucial to ensurebelieve that if there is some residual renal function, as
during the first year or two of renal replacement therapy, compliance. Blake used questionnaires in his study, but
in the individual patient, how do you assess complianceyou can treat with CAPD almost any individual irrespec-
tive of his or her weight. All problems start when the other than, of course, the “look-them-in-the-eye” test?
Dr. Oreopoulos: You should suspect non-compliancepatient becomes anuric. In our experience, however, the
required KT/V targets need not necessarily be as high every time you find an unexplained increase in serum
creatinine in the presence of the same residual creatininein the anuric patient; we found that, after you provide a
KT/V over 1.75, the survival rate is excellent: 80% the clearance. In cases like that, you can measure creatinine
in the effluent; if it is 15% greater than the effluentfirst 2 years. Is it possible that the anuric patient does
not need a clearance as high as that in the patient with creatinine value established in the baseline period, you
should suspect non-compliance. It would be likely thatresidual renal function? Confirmation of our observation
with prospective studies is required. the patient had been skipping dialysis for some time
prior to collection and that on the day of the collectionDr. Singh: There appears to be a striking correlation
between membrane permeability characteristics and mor- was washing out the accumulated creatinine. I believe
that the “look-them-in-the-eye” test is a good and reli-tality. This relationship would suggest that peritoneal
equilibration test (PET) studies should become an inte- able measure. The question, “Do you do all dialysis ex-
changes?” emphasizes the importance of complying withgral and early part of the evaluation and management
of virtually every PD patient. Can you tell us about your the prescription. Even if patients lie, at least they get
the message. It is interesting that Blake relied on anpractice?
Dr. Oreopoulos: I will tell you what we are doing in anonymous questionnaire [92]. He assumed that the pa-
tients would tell the truth anonymously, but that assump-our unit and what are the DOQI recommendations. We
do an Adequestt, which provides measurement of PET, tion is open to criticism. Interestingly, he found a greater
degree of non-compliance in the US than in Canada;KT/V, weekly creatinine clearance (WCC), and NPNA
in each of our new patients; we do not do it during this difference might explain some of the observed differ-
ence in mortality rates between the two populations [113,the first two to three weeks of CAPD, because a PET
performed within the first week after initiation of perito- 114]. In this area, Bernardini and Piraino and colleagues
provided the gold standard [115]. They went to theirneal dialysis can yield a higher transport result than
would a PET performed a few weeks later [112]. The patients’ houses and measured the dialysate inventory.
They compared the actual number of bags with the num-DOQI recommends that we obtain baseline measure-
ments of KT/V and creatinine clearance two or three ber that the patient should have on hand if the patient
is compliant with the dialysis regimen. They also foundtimes during the first six months, and thus obtain a solid
baseline value, and then measure these parameters every that a large percentage of their patients were noncompli-
ant. I believe that the companies that deliver the dialysis6 to 12 months thereafter. However, all one needs to
measure in the followup is the creatinine and urea in solutions might be able to help us in this respect by doing
a monthly inventory.peritoneal effluent and urine. Repeating the PET is un-
necessary because usually it does not change. You should Dr. Suphamai Bunnapradist (Renal Fellow, Division
of Nephrology, New England Medical Center): Wouldperform a formal equilibration test only if there is an
unexpected change in either peritoneal creatinine equili- you please comment on target KT/V in nocturnal inter-
mittent peritoneal dialysis? Is it different from the targetbration or ultrafiltration. In our unit, we ask the patients
to bring a 24-hour urine specimen every second visit, in CAPD?
Dr. Oreopoulos: If control of the peak urea nitrogenand we analyze this for creatinine and urea clearances
because we know that patients who have adequate resid- concentration is critical in preventing uremic toxicity, as
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suggested by the peak concentration hypothesis, then in Canada approximately 100 new patients per million
population begin dialysis every year; in the United States,any intermittent form of peritoneal dialysis requires a
higher “dose” to maintain the peak concentration below more than 250 new patients per million start dialysis
every year. This difference suggests that the case mix ofthe steady state [14, 15]. The DOQI recommendation for
NIPD is 2.2 for weekly KT/V and 66 liters/week/1.73 m2 the American patients varies from that in Canada. I
believe, however, that a very important reason for thefor weekly creatinine clearance.
Dr. Madias: What do you recommend when you en- higher mortality rate among CAPD patients in the US is
that during the years 1987 to 1989, very few nephrologistscounter discordance between the two indices—KT/V and
creatinine clearance? were concerned about dialysis dose. All patients had the
“standard” scheme of 4 3 2-liter exchanges per day,Dr. Oreopoulos: In responding to this difficult ques-
tion, I will tell you what the DOQI recommends and what irrespective of their residual renal function and perito-
neal permeability. The concepts about dialysis doseI am doing in my unit. The DOQI recommends that you
try to achieve both targets. If you achieve only one of started to enter our regular practice only in the early
nineties. Indeed, when Vonesh and Moran looked atthe two, continue with treatment but watch the patient
carefully. In anuric patients and those on short exchanges the USRDS results in subsequent years, they found an
improvement in the results [116]. They also noted that,with APD, it is easier to achieve KT/V targets than
creatinine clearance targets. On the contrary, in those at least for male patients, mortality rates for CAPD
during recent years were similar to hemodialysis.with some residual renal function, you can achieve creati-
nine clearance easier than KT/V. The hemodialysis com- Dr. Harrington: You used the phrase, as does every-
one in the field, “adequacy” of CAPD. Rather than aim-munity always works with urea targets, so I tend to be
satisfied that I am doing a good job if my patients have ing for “adequate” CAPD therapy, what alterations
would you envision in CAPD solutions, connections, etc.,an adequate KT/V, and I do not worry too much about
the creatinine clearance targets. if we were aiming to optimize CAPD?
Dr. Oreopoulos: Even though we should continue toDr. Madias: You mentioned that the survival of CAPD
patients is similar to that of hemodialysis patients. But work hard to achieve adequate clearances for our pa-
tients, we need better dialysis solutions, and a tremen-analysis of the USRDS data showed that the mortality
rate was higher among CAPD patients. Also, undergoing dous effort has been made in the last few years to develop
them. We have great difficulty in maintaining our perito-CAPD in the US was a risk factor for mortality in the
CANUSA study. Could you please comment on these neal dialysis patients over long periods. We all have
patients who have been on CAPD for four to five years.issues?
Dr. Oreopoulos: Nick is referring to the article by However, only a few patients have been on CAPD for
more than 10 years. Only one of my patients has beenBloembergen et al [113]. These authors studied a cohort
of CAPD patients during the period of 1987 to 1989 and on CAPD for almost 20 years. In any event, these long-
term survivors are an exception. I believe this is becauseindeed found a higher mortality rate among the CAPD
patients than in hemodialysis patients, especially among the peritoneal membrane undergoes deleterious alter-
ations when it is exposed to the solutions currently usedelderly diabetics. This study had a rather unusual meth-
odology in that it treated each patient as a new patient over long periods. These changes lead on the one hand
to poor ultrafiltration and on the other to impairmenteach year and defined their therapeutic modality as the
one in place on January 1st of that year. In other words, of the defense mechanisms of the peritoneal cavity, prob-
ably because of severe damage to the mesothelial cells.it was a mixture of incident and prevalent patients, some
of whom must have been anuric. Also, the authors did As a result, peritonitis in patients who have been on
CAPD for five or six years or more is much more severenot compare the relative incidence of co-morbidity. On
the contrary, Fenton from the Canadian Registry studied than the peritonitis early in CAPD. I dread the threat
of peritonitis in a long-term patient of mine. I am con-all new patients on CAPD and on hemodialysis and found
that all groups of patients—diabetics, non-diabetics, young vinced that the long-term exposure of the peritoneal
membrane to unphysiologic, that is, bioincompatible, so-and old—had a higher mortality rate with hemodialysis
than with CAPD for at least the first three years of lutions makes an important contribution to these chronic
changes. The present solutions are acidic (pH 5.5) anddialysis [114]. I believe that any method of analysis that
omits, as the Bloembergen study did, the first year of hyperosmotic. The dialysis industry is under tremendous
pressure to come up with new, more “peritonealtreatment for many patients will tend to show hemodialy-
sis in a better light than peritoneal dialysis. friendly” solutions, and I believe that within the next
few years we are going to see new peritoneal solutions.Many other reasons account for the difference be-
tween the US and Canadian reports. Canadian patients In Europe they have developed and use solutions that
contain, instead of glucose as the osmotic agent, a largeseem to be more compliant with their treatment than
are patients in the US [92]. Another big difference is that glucose polymer (Icodextrin), which achieves ultrafiltra-
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tion by an increased oncotic pressure instead of the in- plantation in our efforts to provide our ESRD patients
with the best possible renal replacement treatment.creased osmotic pressure caused by dextrose [117]. Over
the long term, such solutions probably will produce ultra-
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filtration without causing significant peritoneal damage. The Toronto Hospital, Western Division, 399 Bathurst Street, Toronto,
Ontario, Canada M5T 258.Another possible benefit of such solutions is a lower
caloric load and a lower generation of advanced glycosyl-
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